ClinicalTrials.gov record

Completed No phase listed Observational Accepts healthy volunteers Results available

Gardasil Immunogenicity With Needle-Free Injection

ClinicalTrials.gov ID: NCT01924754

Public ClinicalTrials.gov record NCT01924754. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 9, 2026, 3:21 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

GINI: Gardasil Immunogenicity With Needle-free Injection-Safety and Immunogenicity of Gardasil Using IM and ID Needle-free Injection Delivery

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Using biospecimens collected in a trial by the Thai Red Cross AIDS Research Center that studied two new human papillomavirus (HPV) vaccine delivery regimens, the investigators at UCSF will be testing the serum for antibodies to measure the strength of their response to the vaccine.

Study identification

NCT ID: NCT01924754
Recruitment status: Completed
Study type: Observational
Phase: Not listed
Lead sponsor: University of California, San Francisco; Other
Enrollment: 150 participants

Conditions and interventions

Conditions

HPV Seroconversion

Interventions

Not listed

Eligibility (public fields only)

Age range: 18 Years to 26 Years
Sex: Female
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 1, 2014 (Actual)
Primary completion: May 31, 2016 (Actual)
Completion: May 31, 2016 (Actual)
Last update posted: Oct 13, 2021

2014 – 2016

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
University of California, San Francisco	San Francisco	California	94062	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01924754, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 13, 2021 · Synced Nov 9, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01924754 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →